Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

In a recent study posted to the bioRxiv* preprint server, researchers developed covalent nanobodies (single-domain antibodies) to neutralize severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants.
Study: Accelerating PERx Reaction Enables Covalent…
Source: www.news-medical.net – Read more